Specialist pharmacist prescribing in dermatology Authors: William Price, Tanya Bleiker, Caroline Owen Published: 2024 ABSTRACT AbstractAcross the country, pharmacists are developing their professional competencies to move outside the dispensary and directly integrate with specialist teams. Within dermatology, the widespread use of high-cost and high-risk pharmacological interventions presents a range of opportunities for a pharmacist to contribute to safer, more cost-effective use of medicines. As well as using prescribing qualifications to take on clinical workloads, pharmacists can enact cost-saving changes to routine prescribing; improve clinical governance and use their expertise in medicines to effectively advocate for access to new or alternative treatment options, as well as demystify complex funding pathways.Keywords: Pharmacy, dermatology, prescribing, pharmacoeconomics, medicines governance Across the UK, dermatology departments are evolving to incorporate a broader range of staff groups. In challenging times for NHS specialist teams in secondary care, there is a pressing need to use the skills of a multidisciplinary team to maintain robust services. An ageing consultant workforce and limited numbers of training posts has put sustainability pressures on medical staff.1 To help address these problems, specialist dermatology pharmacists have grown in number over the past decade; from a handful of posts in the early 2010s, to >20 pharmacists working directly in departments in all nations of the UK. Pharmacists are well placed to use their prescribing qualifications to not only take on patient cohorts of their own,2 but also augment doctors and nurses’ prescribing skills and aid in navigating increasingly complex UK supply chains and commissioning criteria (Fig. 1).3 I work as the pharmacist for the dermatology department of East Lancashire Hospitals NHS Trust, a post that I have been in since our successful business case for its creation almost 5 years ago. Working with my dermatology colleagues has been the highlight of my career and I hope that my viewpoint in this article can provide a persuasive argument for the value of the role. Important ways in which a dedicated pharmacist can contribute to a dermatology department. The past decade has been a turbulent time for the pharmaceutical industry. A confluence of factors including Brexit, the COVID pandemic and international conflict have increased UK medicines supply chain precarity,4 with shortages and discontinuations becoming discouragingly routine. This has been especially challenging for topical medicines, which are so often foundational to treatment regimens for dermatological disease. Pharmacists can be beneficial to a department when there are so many roadblocks to patients getting the treatment they need in a timely manner. I regularly work with colleagues to actively seek out new or alternative products; represent the department to make changes to local formularies; work with procurement in accessing unlicensed imports and help source manufactured pharmacy specials. Having a personal relationship with the specialist clinicians and meeting the patients struggling to manage their disease face-to-face creates additional motivation to find a solution when a medicines-related difficulty arises. On the other end of the technological spectrum to the established topicals, a variety of biological and novel small molecule drugs are now providing new options for the treatment of recalcitrant dermatoses. Since 2022 there have been no fewer than 13 positive NICE Technology Appraisals for dermatological treatments. Specialist dermatology pharmacists across the country now play central roles in managing groups of patients using these drugs in clinics and in homecare offices.2 With so many options on the table for conditions such as psoriasis and atopic dermatitis, pharmacists have the financial and clinical data to help the clinical team make cost effective and clinically optimal choices. They also have the education and training to navigate the oftentimes convoluted funding pathways of today’s NHS. Clinical staff members are expected to work in a system with its own lexicon of mind-boggling terms: pass through drugs, prior approval systems, specialised commissioning, shared care arrangements and an unending list of TLAs – three-letter acronyms! Pharmacists can cut through the noise and provide plain-spoken answers about access to treatments and how to achieve savings. In conjunction with expert nursing and administrative colleagues in my own department, we have used the deeper connection with pharmacy to completely change how we approach homecare medicines, using shared tracking tools to provide an overview of which prescriptions are due for renewal, and ensuring all staff have access to up-to-date prescribing templates, risk reduction materials and patient education resources. In the past we have made switches to biosimilars, saving tens of thousands of pounds per year on products such etanercept. However, these savings will pale in comparison to those that will be made in the coming year as we transition from originator products for drugs such as ustekinumab and omalizumab, which are now losing patent exclusivity.5 An important delineation should be made between standard pharmacy support and a dedicated departmental pharmacist team member. Most secondary care dermatology teams will have a small amount of pharmacist time allocated to them to participate in business meetings and perhaps respond to medicines-related queries and Freedom of Information requests. However, this is a very different level of service from what can be offered by a pharmacist that is integrated directly into the specialist team. Having a dedicated pharmacist creates a much deeper relationship and appreciation of the pragmatic effects of medicines-related changes to clinicians. In my own work, I think this is exemplified by our recent transition to electronic prescribing and electronic patient records (EPR). As a clinic-holder myself, I have a first-hand understanding of the time pressure of appointment slots and the stress that can come from extra clicks and boxes on the EPR when prescribing and writing notes. I have taken ownership of the electronic dermatology drug catalogue and worked hard to have dosing instruction templates ready to go for all our products; to have protocols in place for electronic administration recording of our specialist topical treatments and am currently working on proformas to support consistent prescribing of commonly used high-risk drugs and make clinic coding more efficient. Pharmacists can also influence prescribing practice beyond the walls of the hospital. Recent changes to isotretinoin prescribing have had a big impact on dermatology teams. I took part in the work of the MHRA’s Implementation Advisory Expert Working Group for the isotretinoin report, advocating for the expansion of responsibilities for isotretinoin initiation to a wider range of team members such as the most senior nurses and pharmacists as part of dermatologist-led teams.6 Many facets of the isotretinoin changes have been controversial, but this clarification of the suitable staff members to initiate treatment has been a positive move, allowing senior pharmacist and nurse prescribers to be more independent members of the team and take on a cohort of patients eith acne, one of the most common dermatological complaints, which previously required direct consultant supervision. Specialist pharmacists are taking on important responsibilities across the board in medical and surgical teams. Despite the recent surge of interest in dermatology pharmacist posts, it is still a nascent role when compared to areas such as renal, oncology and critical care pharmacy, where the profession has fully established support networks.7, 8, 9 As existing post-holders develop their roles (Fig. 2), more opportunities are arising to create networks and pass on learning to trainee pharmacists, primary care colleagues in GP surgeries and community pharmacy teams. This training to enhance the skillset of pharmacists across care sectors is very much aligned with the NHS priorities for 2024/25 and in particular the Pharmacy First scheme, which aims to give patients quicker and more convenient access to safe and high-quality healthcare.10 Aspects of the role of the dermatology pharmacist. I hope that this article has touched upon areas that might spark an interest in your own area of work. Pharmacists are the experts in medicine and have a lot to offer to a specialty like dermatology that is growing more complex and varied in its treatment modalities every year. Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. CRediT authorship contribution statement William Price: Writing – review & editing, Writing – original draft, Conceptualization. Tanya Bleiker: Writing – review & editing. Caroline Owen: Writing – review & editing. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Footnotes This article reflects the opinions of the author(s) and should not be taken to represent the policy of the Royal College of Physicians unless specifically stated. References